Bacil Pharma Ltd — Updates, 05-06-2025: Company Update

Bacil Pharma has announced a board meeting on the listing approval received from BSE for 84.63 lakh equity shares of Rs. 10 each, issued at a premium of Rs. 22 per share to non-promoters on a preferential basis. This listing expands the company's equity base, potentially improving liquidity and broadening its investor profile.